FDA Warns That Teva’s Lansoprazole Can Block Syringes, Feeding Tubes

The FDA has issued a MedWatch warning and a letter to healthcare professionals warning Teva Pharmaceutical’s generic lansoprazole delayed-release orally disintegrating tablets (ODT) can block oral syringes and feeding tubes. The product is clogging gastric and jejunostomy oral syringes and feeding tubes when lansoprazole is administered through them since the tablets are not fully disintegrating in water, or are forming clumps, the FDA says in a letter released April 15. Clumps can stick to the inside walls of oral syringes and feeding tubes. In some cases, patients have sought emergency medical assistance, including unclogging or removing and replacing feeding tubes, the FDA says.
Generic Line